Quick Heal Technologies Ltd

Quick Heal Tech Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Quick Heal Technologies Ltd

₹ 499 -0.91%
26 Apr - close price
quickheal.com BSE: 539678 NSE : QUICKHEAL
About

Quick Heal Technologies is engaged in the business of providing security software products. The Company caters to both domestic and international market.

Key Points

Market Presence
With over 30% of the market share in India and a nationwide distribution channel comprising over 200 Tier I distributors and over 30,000 Tier II and Tier III distributors in the retail segment. A robust country-wide distribution network comprising more than 30,000 distributors in 22 cities of India and an International presence in around 47 countries, further supported by operational entities in five countries and very high brand value derived from well-entrenched industry presence and expertise for more than 25+ years. [1] [2]

Website BSE NSE
  • Market Cap ₹ 2,668 Cr.
  • Current Price ₹ 499
  • High / Low ₹ 600 / 136
  • Stock P/E 111
  • Book Value ₹ 81.6
  • Dividend Yield 0.50 %
  • ROCE 6.11 %
  • ROE 5.62 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 90.8%

Cons

  • Stock is trading at 6.11 times its book value
  • The company has delivered a poor sales growth of -1.39% over past five years.
  • Tax rate seems low
  • Company has a low return on equity of 6.31% over last 3 years.
  • Earnings include an other income of Rs.21.4 Cr.
  • Company has high debtors of 165 days.
  • Working capital days have increased from 168 days to 316 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: IT - Software Industry: Computers - Software - Medium / Small

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
106 54 104 80 104 61 101 67 49 51 78 82 80
52 50 57 59 69 60 73 78 65 67 67 70 70
Operating Profit 54 4 46 20 35 1 28 -11 -16 -15 11 12 10
OPM % 51% 8% 45% 26% 33% 2% 28% -16% -32% -30% 14% 14% 13%
6 4 4 4 4 3 5 4 10 5 6 4 7
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 5 4 4 5 5 4 4 4 4 3 3 3 3
Profit before tax 55 4 46 20 34 0 30 -11 -10 -13 13 12 14
Tax % 27% 26% 24% 27% 23% 25% 25% 25% 33% 4% 4% 20% -4%
40 3 35 14 26 0 22 -8 -7 -13 13 10 14
EPS in Rs 6.23 0.56 5.98 2.47 4.49 0.05 3.81 -1.54 -1.23 -2.43 2.43 1.88 2.62
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
205 244 284 298 299 316 313 283 334 342 278 292
101 138 190 192 202 192 183 190 192 236 275 274
Operating Profit 104 106 94 107 97 124 129 93 141 106 3 17
OPM % 51% 43% 33% 36% 33% 39% 41% 33% 42% 31% 1% 6%
11 -6 8 9 23 22 23 29 24 15 22 21
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 4 11 20 24 31 27 24 22 19 17 16 13
Profit before tax 111 89 82 93 90 119 129 100 146 104 9 26
Tax % 30% 31% 32% 33% 34% 34% 35% 27% 27% 24% 17% 8%
78 62 56 62 59 79 84 74 107 78 8 24
EPS in Rs 101.58 10.08 9.22 8.91 8.44 11.21 11.90 11.47 16.63 13.48 1.45 4.50
Dividend Payout % 2% 74% 81% 28% 30% 27% 17% 35% 24% 33% 172% 67%
Compounded Sales Growth
10 Years: 2%
5 Years: -1%
3 Years: -4%
TTM: 5%
Compounded Profit Growth
10 Years: -10%
5 Years: -23%
3 Years: -39%
TTM: 1237%
Stock Price CAGR
10 Years: %
5 Years: 18%
3 Years: 37%
1 Year: 264%
Return on Equity
10 Years: 11%
5 Years: 9%
3 Years: 6%
Last Year: 6%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 8 61 61 70 70 70 71 64 64 58 53 54
Reserves 278 275 277 570 609 667 724 584 692 569 367 383
0 0 0 0 0 0 0 0 0 0 0 0
29 47 96 87 71 57 62 52 75 89 73 76
Total Liabilities 314 383 434 727 751 794 857 700 831 716 493 513
38 82 111 142 185 173 165 158 146 137 124 117
CWIP 29 55 74 55 14 14 11 3 2 0 0 3
Investments 140 135 139 128 211 325 401 320 428 321 198 191
107 110 110 403 341 282 281 218 255 258 170 202
Total Assets 314 383 434 727 751 794 857 700 831 716 493 513

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
68 63 78 81 50 96 63 71 100 78 31 18
-63 -63 -57 -167 -90 -119 -39 146 -94 130 188 6
-1 -2 -18 189 -20 -19 -24 -221 0 -214 -212 2
Net Cash Flow 3 -2 3 104 -61 -42 -0 -4 6 -6 6 26

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 138 106 87 118 116 119 146 146 164 185 161 165
Inventory Days 173
Days Payable 919
Cash Conversion Cycle 138 106 -659 118 116 119 146 146 164 185 161 165
Working Capital Days 103 53 -20 34 46 69 92 96 97 102 84 316
ROCE % 44% 34% 24% 19% 14% 18% 18% 14% 20% 15% 0%

Shareholding Pattern

Numbers in percentages

6 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
73.02% 72.99% 72.92% 72.86% 72.84% 72.78% 73.08% 73.08% 73.08% 73.06% 72.76% 72.48%
0.52% 0.97% 1.57% 1.77% 1.74% 1.76% 2.17% 2.04% 2.02% 1.56% 1.66% 1.65%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.13% 1.44% 2.06%
26.47% 26.04% 25.51% 25.37% 25.42% 25.45% 24.76% 24.89% 24.91% 24.23% 24.13% 23.81%
No. of Shareholders 63,17369,62166,99267,49166,76975,04466,02865,11963,44557,52850,24946,923

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls